Pathway Name Avg Num Perturbations Total Perturbations Num Entities Min Mean Truth Max Mean Truth Min Mean Within Max Mean Within Min Mean Any Max Mean Within FOXM1 transcription factor network 167.0 8555.0 51.0 -0.04 0.826 1000.0 -1000.0 -0.096 -1000.0 Glypican 2 network 120.0 481.0 4.0 0.084 0.138 1000.0 -1000.0 0.016 -1000.0 Angiopoietin receptor Tie2-mediated signaling 92.0 8182.0 88.0 -0.504 0.104 1000.0 -1000.0 -0.053 -1000.0 Aurora B signaling 90.0 6092.0 67.0 -0.152 0.295 1000.0 -1000.0 -0.028 -1000.0 HIF-1-alpha transcription factor network 85.0 6516.0 76.0 -0.045 0.434 1000.0 -1000.0 -0.036 -1000.0 Signaling events mediated by the Hedgehog family 77.0 4053.0 52.0 -0.231 0.109 1000.0 -1000.0 -0.025 -1000.0 PLK1 signaling events 58.0 5008.0 85.0 -0.054 0.205 1000.0 -1000.0 -0.025 -1000.0 Endothelins 55.0 5288.0 96.0 -0.3 0.201 1000.0 -1000.0 -0.035 -1000.0 Aurora C signaling 49.0 349.0 7.0 -0.0 0.173 1000.0 -1000.0 -0.005 -1000.0 Signaling mediated by p38-alpha and p38-beta 43.0 1934.0 44.0 -0.096 0.021 1000.0 -1000.0 -0.02 -1000.0 Visual signal transduction: Cones 42.0 1615.0 38.0 -0.084 0.12 1000.0 -1000.0 -0.015 -1000.0 Fc-epsilon receptor I signaling in mast cells 41.0 3995.0 97.0 -0.11 0.021 1000.0 -1000.0 -0.04 -1000.0 FOXA2 and FOXA3 transcription factor networks 40.0 1869.0 46.0 -0.227 0.152 1000.0 -1000.0 -0.091 -1000.0 Signaling events regulated by Ret tyrosine kinase 39.0 3254.0 82.0 -0.084 0.064 1000.0 -1000.0 -0.047 -1000.0 Osteopontin-mediated events 38.0 1462.0 38.0 -0.004 0.252 1000.0 -1000.0 -0.027 -1000.0 IL4-mediated signaling events 38.0 3503.0 91.0 -0.64 0.351 1000.0 -1000.0 -0.112 -1000.0 BMP receptor signaling 37.0 2999.0 81.0 -0.186 0.237 1000.0 -1000.0 -0.021 -1000.0 amb2 Integrin signaling 36.0 2967.0 82.0 -0.307 0.08 1000.0 -1000.0 -0.028 -1000.0 RXR and RAR heterodimerization with other nuclear receptor 33.0 1766.0 52.0 -0.142 0.045 1000.0 -1000.0 -0.031 -1000.0 Ephrin B reverse signaling 32.0 1555.0 48.0 -0.077 0.08 1000.0 -1000.0 -0.027 -1000.0 Visual signal transduction: Rods 32.0 1685.0 52.0 -0.084 0.102 1000.0 -1000.0 -0.032 -1000.0 Syndecan-1-mediated signaling events 29.0 999.0 34.0 -0.0 0.221 1000.0 -1000.0 -0.021 -1000.0 p75(NTR)-mediated signaling 28.0 3529.0 125.0 -0.141 0.141 1000.0 -1000.0 -0.044 -1000.0 IL23-mediated signaling events 28.0 1725.0 60.0 -0.182 0.026 1000.0 -1000.0 -0.084 -1000.0 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 26.0 1822.0 68.0 -0.152 0.068 1000.0 -1000.0 -0.049 -1000.0 LPA4-mediated signaling events 25.0 300.0 12.0 -0.074 0.0 1000.0 -1000.0 -0.015 -1000.0 Integrins in angiogenesis 25.0 2122.0 84.0 -0.09 0.248 1000.0 -1000.0 -0.038 -1000.0 TCGA08_retinoblastoma 24.0 199.0 8.0 -0.021 0.099 1000.0 -1000.0 -0.003 -1000.0 Neurotrophic factor-mediated Trk receptor signaling 24.0 2902.0 120.0 -0.165 0.144 1000.0 -1000.0 -0.043 -1000.0 Arf6 signaling events 23.0 1452.0 62.0 -0.108 0.073 1000.0 -1000.0 -0.025 -1000.0 Canonical Wnt signaling pathway 23.0 1214.0 51.0 -0.211 0.095 1000.0 -1000.0 -0.026 -1000.0 Thromboxane A2 receptor signaling 22.0 2411.0 105.0 -0.105 0.073 1000.0 -1000.0 -0.036 -1000.0 Presenilin action in Notch and Wnt signaling 22.0 1357.0 61.0 -0.211 0.095 1000.0 -1000.0 -0.027 -1000.0 Aurora A signaling 22.0 1354.0 60.0 -0.028 0.197 1000.0 -1000.0 -0.019 -1000.0 Glucocorticoid receptor regulatory network 21.0 2406.0 114.0 -0.284 0.175 1000.0 -1000.0 -0.039 -1000.0 Reelin signaling pathway 21.0 1208.0 56.0 -0.038 0.047 1000.0 -1000.0 -0.023 -1000.0 HIF-2-alpha transcription factor network 21.0 942.0 43.0 -0.137 0.15 1000.0 -1000.0 -0.036 -1000.0 IL6-mediated signaling events 21.0 1592.0 75.0 -0.153 0.049 1000.0 -1000.0 -0.036 -1000.0 EGFR-dependent Endothelin signaling events 21.0 445.0 21.0 -0.022 0.073 1000.0 -1000.0 -0.03 -1000.0 Wnt signaling 20.0 146.0 7.0 -0.027 0.039 1000.0 -1000.0 -0.011 -1000.0 Glypican 1 network 18.0 884.0 48.0 -0.051 0.037 1000.0 -1000.0 -0.021 -1000.0 FoxO family signaling 18.0 1171.0 64.0 0.0 0.21 1000.0 -1000.0 -0.054 -1000.0 Effects of Botulinum toxin 18.0 493.0 26.0 -0.0 0.041 1000.0 -1000.0 -0.007 -1000.0 Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 18.0 601.0 33.0 -0.08 0.097 1000.0 -1000.0 -0.023 -1000.0 Nongenotropic Androgen signaling 17.0 898.0 52.0 -0.069 0.05 1000.0 -1000.0 -0.021 -1000.0 ErbB2/ErbB3 signaling events 16.0 1058.0 65.0 -0.048 0.03 1000.0 -1000.0 -0.055 -1000.0 Noncanonical Wnt signaling pathway 16.0 425.0 26.0 -0.047 0.039 1000.0 -1000.0 -0.027 -1000.0 TCGA08_p53 16.0 113.0 7.0 -0.02 0.019 1000.0 -1000.0 -0.008 -1000.0 Syndecan-4-mediated signaling events 16.0 1079.0 67.0 -0.043 0.139 1000.0 -1000.0 -0.031 -1000.0 S1P4 pathway 16.0 419.0 25.0 -0.028 0.027 1000.0 -1000.0 -0.014 -1000.0 ErbB4 signaling events 15.0 1080.0 69.0 -0.114 0.138 1000.0 -1000.0 -0.025 -1000.0 Syndecan-2-mediated signaling events 15.0 1049.0 69.0 -0.045 0.059 1000.0 -1000.0 -0.035 -1000.0 PDGFR-alpha signaling pathway 15.0 689.0 44.0 -0.187 0.038 1000.0 -1000.0 -0.03 -1000.0 IL1-mediated signaling events 15.0 965.0 62.0 -0.077 0.041 1000.0 -1000.0 -0.04 -1000.0 Regulation of Androgen receptor activity 15.0 1072.0 70.0 -0.141 0.125 1000.0 -1000.0 -0.038 -1000.0 PLK2 and PLK4 events 14.0 42.0 3.0 -0.005 0.039 1000.0 -1000.0 -0.018 -1000.0 EPHB forward signaling 14.0 1226.0 85.0 -0.031 0.09 1000.0 -1000.0 -0.043 -1000.0 Calcium signaling in the CD4+ TCR pathway 14.0 453.0 31.0 -0.036 0.036 1000.0 -1000.0 -0.034 -1000.0 LPA receptor mediated events 14.0 1496.0 102.0 -0.057 0.071 1000.0 -1000.0 -0.048 -1000.0 Nephrin/Neph1 signaling in the kidney podocyte 13.0 442.0 34.0 -0.034 0.057 1000.0 -1000.0 -0.023 -1000.0 Lissencephaly gene (LIS1) in neuronal migration and development 13.0 711.0 54.0 -0.032 0.109 1000.0 -1000.0 -0.024 -1000.0 Nectin adhesion pathway 13.0 848.0 63.0 -0.039 0.051 1000.0 -1000.0 -0.031 -1000.0 S1P5 pathway 13.0 235.0 17.0 -0.02 0.021 1000.0 -1000.0 -0.002 -1000.0 FAS signaling pathway (CD95) 13.0 632.0 47.0 -0.226 0.034 1000.0 -1000.0 -0.033 -1000.0 Class IB PI3K non-lipid kinase events 13.0 39.0 3.0 -0.008 0.008 1000.0 -1000.0 -0.021 -1000.0 IL12-mediated signaling events 12.0 1081.0 87.0 -0.131 0.06 1000.0 -1000.0 -0.068 -1000.0 Signaling events mediated by PTP1B 12.0 956.0 76.0 -0.053 0.074 1000.0 -1000.0 -0.035 -1000.0 Ceramide signaling pathway 12.0 986.0 76.0 -0.02 0.073 1000.0 -1000.0 -0.026 -1000.0 BCR signaling pathway 12.0 1207.0 99.0 -0.046 0.08 1000.0 -1000.0 -0.044 -1000.0 Plasma membrane estrogen receptor signaling 12.0 1090.0 86.0 -0.061 0.057 1000.0 -1000.0 -0.037 -1000.0 Signaling events mediated by Stem cell factor receptor (c-Kit) 12.0 952.0 78.0 -0.047 0.023 1000.0 -1000.0 -0.032 -1000.0 Coregulation of Androgen receptor activity 11.0 891.0 76.0 -0.062 0.096 1000.0 -1000.0 -0.013 -1000.0 BARD1 signaling events 11.0 631.0 57.0 -0.046 0.117 1000.0 -1000.0 -0.032 -1000.0 Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 11.0 960.0 85.0 -0.07 0.037 1000.0 -1000.0 -0.033 -1000.0 S1P1 pathway 11.0 398.0 36.0 -0.081 0.021 1000.0 -1000.0 -0.03 -1000.0 Stabilization and expansion of the E-cadherin adherens junction 11.0 868.0 74.0 -0.098 0.073 1000.0 -1000.0 -0.051 -1000.0 Signaling events mediated by HDAC Class III 10.0 403.0 40.0 -0.06 0.068 1000.0 -1000.0 -0.03 -1000.0 TCR signaling in naïve CD8+ T cells 10.0 994.0 93.0 -0.027 0.032 1000.0 -1000.0 -0.04 -1000.0 Caspase cascade in apoptosis 9.0 739.0 74.0 -0.028 0.085 1000.0 -1000.0 -0.039 -1000.0 Syndecan-3-mediated signaling events 9.0 340.0 35.0 -0.116 0.045 1000.0 -1000.0 -0.018 -1000.0 Regulation of p38-alpha and p38-beta 9.0 503.0 54.0 -0.039 0.056 1000.0 -1000.0 -0.039 -1000.0 Signaling events mediated by VEGFR1 and VEGFR2 9.0 1213.0 125.0 -0.187 0.041 1000.0 -1000.0 -0.037 -1000.0 IL2 signaling events mediated by STAT5 8.0 184.0 22.0 -0.026 0.105 1000.0 -1000.0 -0.025 -1000.0 Ephrin A reverse signaling 7.0 52.0 7.0 -0.013 0.029 1000.0 -1000.0 -0.013 -1000.0 Hedgehog signaling events mediated by Gli proteins 7.0 482.0 65.0 -0.139 0.048 1000.0 -1000.0 -0.033 -1000.0 IL27-mediated signaling events 7.0 359.0 51.0 -0.045 0.038 1000.0 -1000.0 -0.05 -1000.0 PDGFR-beta signaling pathway 7.0 707.0 97.0 -0.036 0.052 1000.0 -1000.0 -0.041 -1000.0 Signaling events mediated by PRL 7.0 268.0 34.0 -0.023 0.09 1000.0 -1000.0 -0.029 -1000.0 Regulation of nuclear SMAD2/3 signaling 6.0 845.0 136.0 -0.178 0.071 1000.0 -1000.0 -0.036 -1000.0 JNK signaling in the CD4+ TCR pathway 6.0 103.0 17.0 -0.005 0.046 1000.0 -1000.0 -0.018 -1000.0 Class I PI3K signaling events 6.0 509.0 73.0 -0.039 0.049 1000.0 -1000.0 -0.024 -1000.0 Insulin Pathway 6.0 505.0 74.0 -0.1 0.051 1000.0 -1000.0 -0.033 -1000.0 VEGFR1 specific signals 6.0 369.0 56.0 -0.187 0.049 1000.0 -1000.0 -0.029 -1000.0 Sphingosine 1-phosphate (S1P) pathway 5.0 162.0 28.0 -0.02 0.032 1000.0 -1000.0 -0.018 -1000.0 Cellular roles of Anthrax toxin 5.0 230.0 39.0 -0.033 0.028 1000.0 -1000.0 -0.019 -1000.0 EPO signaling pathway 5.0 319.0 55.0 -0.024 0.046 1000.0 -1000.0 -0.027 -1000.0 mTOR signaling pathway 5.0 310.0 53.0 -0.054 0.024 1000.0 -1000.0 -0.026 -1000.0 IFN-gamma pathway 5.0 395.0 68.0 -0.027 0.062 1000.0 -1000.0 -0.04 -1000.0 ceramide signaling pathway 5.0 270.0 49.0 -0.01 0.026 1000.0 -1000.0 -0.035 -1000.0 Role of Calcineurin-dependent NFAT signaling in lymphocytes 5.0 418.0 83.0 -0.062 0.04 1000.0 -1000.0 -0.018 -1000.0 Retinoic acid receptors-mediated signaling 5.0 338.0 58.0 -0.095 0.04 1000.0 -1000.0 -0.028 -1000.0 HIV-1 Nef: Negative effector of Fas and TNF-alpha 5.0 255.0 45.0 -0.024 0.049 1000.0 -1000.0 -0.042 -1000.0 Arf6 trafficking events 5.0 360.0 71.0 -0.039 0.038 1000.0 -1000.0 -0.033 -1000.0 Regulation of Telomerase 5.0 599.0 102.0 -0.02 0.094 1000.0 -1000.0 -0.034 -1000.0 Ras signaling in the CD4+ TCR pathway 5.0 87.0 17.0 -0.004 0.03 1000.0 -1000.0 -0.019 -1000.0 Arf6 downstream pathway 4.0 177.0 43.0 -0.051 0.055 1000.0 -1000.0 -0.024 -1000.0 Signaling events mediated by HDAC Class I 4.0 444.0 104.0 -0.034 0.047 1000.0 -1000.0 -0.03 -1000.0 IL2 signaling events mediated by PI3K 4.0 239.0 58.0 -0.014 0.07 1000.0 -1000.0 -0.037 -1000.0 E-cadherin signaling in the nascent adherens junction 4.0 356.0 76.0 -0.031 0.056 1000.0 -1000.0 -0.044 -1000.0 p38 MAPK signaling pathway 4.0 195.0 44.0 -0.008 0.062 1000.0 -1000.0 -0.019 -1000.0 Signaling events mediated by HDAC Class II 3.0 261.0 75.0 -0.021 0.057 1000.0 -1000.0 -0.024 -1000.0 Circadian rhythm pathway 3.0 73.0 22.0 -0.004 0.05 1000.0 -1000.0 -0.02 -1000.0 Class I PI3K signaling events mediated by Akt 3.0 217.0 68.0 -0.028 0.046 1000.0 -1000.0 -0.025 -1000.0 Signaling mediated by p38-gamma and p38-delta 3.0 55.0 15.0 -0.018 0.021 1000.0 -1000.0 -0.021 -1000.0 TCGA08_rtk_signaling 3.0 97.0 26.0 -0.011 0.047 1000.0 -1000.0 -0.006 -1000.0 IGF1 pathway 3.0 227.0 57.0 -0.032 0.048 1000.0 -1000.0 -0.03 -1000.0 S1P3 pathway 3.0 133.0 42.0 -0.025 0.034 1000.0 -1000.0 -0.025 -1000.0 Canonical NF-kappaB pathway 2.0 81.0 39.0 -0.016 0.042 1000.0 -1000.0 -0.018 -1000.0 Paxillin-independent events mediated by a4b1 and a4b7 2.0 74.0 37.0 -0.025 0.05 1000.0 -1000.0 -0.019 -1000.0 TRAIL signaling pathway 2.0 106.0 48.0 -0.017 0.045 1000.0 -1000.0 -0.023 -1000.0 E-cadherin signaling in keratinocytes 2.0 122.0 43.0 -0.014 0.039 1000.0 -1000.0 -0.024 -1000.0 Regulation of cytoplasmic and nuclear SMAD2/3 signaling 1.0 23.0 23.0 0.0 0.036 1000.0 -1000.0 -0.017 -1000.0 a4b1 and a4b7 Integrin signaling 1.0 7.0 5.0 0.019 0.03 1000.0 -1000.0 0.018 -1000.0 Insulin-mediated glucose transport 1.0 59.0 32.0 -0.016 0.038 1000.0 -1000.0 -0.016 -1000.0 Paxillin-dependent events mediated by a4b1 1.0 54.0 36.0 -0.036 0.038 1000.0 -1000.0 -0.025 -1000.0 Atypical NF-kappaB pathway 1.0 38.0 31.0 -0.017 0.029 1000.0 -1000.0 -0.022 -1000.0 Rapid glucocorticoid signaling 1.0 27.0 20.0 -0.008 0.026 1000.0 -1000.0 -0.008 -1000.0 E-cadherin signaling events 1.0 6.0 5.0 0.019 0.039 1000.0 -1000.0 0.017 -1000.0 Arf1 pathway 1.0 90.0 54.0 -0.008 0.034 1000.0 -1000.0 -0.016 -1000.0 Sumoylation by RanBP2 regulates transcriptional repression 0.0 19.0 27.0 -0.019 0.045 1000.0 -1000.0 -0.028 -1000.0 Alternative NF-kappaB pathway 0.0 0.0 13.0 -0.0 0.055 1000.0 -1000.0 0.0 -1000.0 Total 2441 144891 7203 -9.66251921749 10.9465715856 131000 -131000 -3.8515691803 -131000